Sales Growth YoY (Last Twelve Months): NewAmsterdam Pharma Corp (NAMS)

Graphic logo of NewAmsterdam Pharma (NAMS)

NewAmsterdam Pharma (NAMS) is strengthening its market position through patents for a unique cholesterol drug, confirming the brand's high scientific reputation among cardiologists. The trailing 12-month sales performance relative to the previous year demonstrates a growth trajectory where the metric reached the level of -26.90. Simultaneously, the company is implementing digital patient monitoring, reducing transport emissions and the environmental footprint of its research.

Sales Growth YoY (Last Twelve Months): NewAmsterdam Pharma N.V. (NAMS) for 02/11/2024 - 11/18/2026

Summary analytical data breakdowns for NewAmsterdam Pharma N.V. (NAMS)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:NewAmsterdam Pharma
Mass-produced product of NewAmsterdam Pharma Company

The development of unique oral CETP inhibitors for statin-intolerant patients creates potential for significant pricing power for NewAmsterdam Pharma (NAMS). This expansion trend is reflected in the TTM annual revenue growth rate, which captures the market consensus regarding the business's operational strength. This metric measures the cash change in sales volume over the last twelve months based on daily updates. The steady growth of this indicator confirms the company's fundamental resilience and commercial success.

Competitor analysis for NewAmsterdam Pharma

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) soleno.life SLNO|Sales Growth YoY (TTM) FOLD (amicusrx.com)|Annual Revenue Growth (Last Twelve Months) 89bio (ETNB)|Agios - Sales Growth YoY (TTM)|Structure Corp - Revenue Change YoY (Last 12 Months)|mimedx.com (MDXG) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Sales Growth RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) MBX|Sales Growth YoY (Last Twelve Months) Altimmune Pharma (ALT)|Sales Growth YoY (Last Twelve Months) AARD (Aardvark Therapeutics Corp)|Sales Growth YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)